Abstract:BACKGROUND:This study was designed to obtain a recombinant retroviral vector containing the human hepatocellular carcinoma-related gene ANGPTL4 (angiopoietin-like 4) cDNA and to evaluate the anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.METHODS:ANGPTL4 cDNA was cloned in vitro from normal human liver cells HL-7702 by using RT-PCR, and then subcloned into the plasmid vector pMSCV and sequenced. The retroviral plasmid vectors pMSCV-ANGPTL4, pVSV, and pGAG-POL were co-transfected into the packaging cell line 293 EBNA under mediation of lipofectamine. A high-titer retrovirus was obtained as a result, and HepG2 cells were infected with this retrovirus in vitro. Flow cytometry and fluorescence microscopy were used to detect expression of green fluorescence protein (GFP). The expression of ANGPTL4 mRNA in HepG2-ANGPTL4 cells was investigated using RT-PCR. The formation of tumors in nude mice and MTT assays were used to detect the growth of HepG2-ANGPTL4 cells in vivo and in vitro, respectively.RESULTS:The cDNA sequence of the cloned ANGPTL4 gene was consistent with the recently reported sequence. Thus, the recombinant retroviral vector pMSCV-ANGPTL4 was constructed successfully. The titer of the packaged recombinant retrovirus was 1.4 x 10(6) infective viral grains/ml, and the rate of HepG2-ANGPTL4 cells expressing GFP was 68.45%, with an average intensity of fluorescence 31.67 times greater in HepG2-ANGPTL4 cells than in HepG2 cells. The expression of ANGPTL4 mRNA in HepG2-ANGPTL4 cells was higher than in HepG2-pMSCV cells (154% higher) or HepG2 cells (161% higher). The proliferation rate of HepG2-ANGPTL4 cells in vitro was obviously lower than those of HepG2-pMSCV cells and HepG2 cells (P <0.01). The mean volume and weight of tumors seeded from HepG2-ANGPTL4 cells were obviously lower than the mean volume or weight of tumors seeded from HepG2 cells and HepG2-pMSCV cells (P <0.01).CONCLUSION:A stable ANGPTL4-transfected human liver cancer cell line HepG2-ANGPTL4 has been created. The transfer of the human ANGPTL4 gene mediated by a retroviral vector is a possibly effective approach for liver cancer therapy.

Construction and Application of an Artificial Microrna Expression Vector for Inhibiting PAR4

Downregulation of Proteinase Activated Receptor 4 Inhibits Migration of SW620 Human Colorectal Cancer Cells

Targeting The Urokinase Plasminogen Activator Receptor With A Monoclonal Antibody Impairs The Growth Of Human Colorectal Cancer In The Liver

An Artificial Mirna Against Hpse Suppresses Melanoma Invasion Properties, Correlating With A Down-Regulation Of Chemokines And Mapk Phosphorylation

Lentiviral Mir30-Based Rna Interference Against Heparanase Suppresses Melanoma Metastasis With Lower Liver And Lung Toxicity

Anti-tumor Effect of Recombinant Retroviral Vector-Mediated Human ANGPTL4 Gene Transfection.

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

The experimental study of short hairpin RNA on the suppression of lung cancer-associated gene

[ANGPTL4 Gene Silencing by Short-Hairpin RNA Inhibits the Migration of Human Colorectal Cancer Cell Line HT29].

Construction of COL1A1 Short Hairpin RNA Vector and Its Effect on Cell Proliferation and Migration of Gastric Cancer Cells

Construction of heparanase gene-targeted small interfering RNA and its gene silencing effect]

Specific Gene Silencing by Artificial MicroRNA

[Construction of Mirna Expression Vector Dual-Targeting on HIF-1α/survivin Genes and Its Effects on Proliferation of Pancreatic Cancer Panc-1 Cell Line].

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

Construction and Application of Inducible Artificial Microrna Expression Vector Targeting Eif3g Gene

Vector construction and silencing effect of HER4 gene targeted small interfering RNA

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.

Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA.

Synthetic Tet-inducible Artificial Micrornas Targeting Β-Catenin or HIF-1α Inhibit Malignant Phenotypes of Bladder Cancer Cells T24 and 5637